Please take part in the international survey on Psychological Service Needs for Food Allergy headed by Dr Rebecca Knibb at Aston University in collaboration Dr Chrissie Jones, Dr Helen Brough, Dr Linda Herbert, Mary Jane Marchisotto, Centres in the UK,

We really welcome the Editorial in the BMJ (18th January 2021)-  “Vaccinating against Covid 19 in People who report Allergies.” Click here to read the editorial The Campaign has had an unprecedented number of calls to our helpline from allergic

We are saddened to learn of the tragic death of Ellen Raffell, aged 16, who sadly died on 31st October 2019. We would like to offer our deepest sympathies to her family at this difficult time. Following the inquest on

Shrimp allergy is a common and serious food allergy that is underdiagnosed and often lifelong.

Acaster Lloyd Consulting are looking for participants to take part in a research study about caregivers’ and children’s Experiences of taking an oral peanut protein powder (immunotherapy) treatment or 2. Their thoughts about how an oral peanut protein powder (immunotherapy)

Aimmune Therapeutics’ PALFORZIA® has been approved by the European Commission as a treatment for peanut allergy. The European Commission (EC) has approved PALFORZIA®  for the treatment of peanut allergy, making it the first treatment for the condition. Produced by Aimmune

Allergy Therapeutics PLC – Sussex-based biotechnology firm focused on allergy vaccines – Initiates peanut allergy biomarker study with Imperial College London to confirm potential of novel peanut vaccine candidate. The study aims to evaluate the novel virus like particle based

The Anaphylaxis Campaign, the only UK-wide charity operating solely for the growing numbers of people at risk from severe allergic reactions, has welcomed a new Ambassador to help raise awareness and create a safer environment for those with allergies. Julianne Ponan,

Dr June Raine, Chief Executive of the Medicines and Healthcare products Regulatory Agency (MHRA), said: “We have this evening (Wednesday 9 December 2020) issued updated guidance to COVID-19 vaccination centres about the management of anaphylaxis, following two reports of anaphylaxis